Effect of murine recombinant interferon-γ in the protection of mice against salmonella

Haruo Matsumura, Kazuyasu Onozuka, Yasuhiko Terada, Yasunobu Nakano, Masayasu Nakano

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The ability of recombinant murine (rMu) interferon (IFN) -γ to activate anti-Salmonella-activity in normal mice and beige mutant (bg/bg) mice with Chediak-Higashi syndrome (CHS) was examined. Previous intraperitoneal (i.p.) injection of rMuIFN-γ (104 U per mouse) significantly hindered the bacterial growth in the peritoneal cavities, spleens and livers of the mice after the i.p. infection with Salmonella enteritidis No. 11 strain. It was also effective on the beige mice that have phagocytic cells with a genetically impaired bactericidal function, suggesting that IFN-γ activates the pathway irrelevant to the beige mutation. The effect was the maximum, when IFN-γ was given 6 h before the challenge. The effect seemed to be due to the augmentation of bactericidal capacity rather than the prevention of systemic spread of bacteria. Recombinant human IFN-αA/D (102-106 U per mouse), which produced effects identical to those of murine IFN-β, did not show such a bactericidal effect. Bactericidal activity enhancement was also seen in mice that had been injected with a small amount of rMuIFN-γ (102 U) and bacterial lipopolysaccharide (LPS) (10 ng) together at 6 h before the challenge, although the IFN-γ or LPS alone at these doses produced very little if any effect. Bactericidal effect enhancement was seen in mice that had been injected with IFN-γ at 6 h and LPS at 3 h before the challenge, while it could be hardly seen in mice injected with them in a reversed order. The simultaneous injections of rMuIFN-γ and LPS at 6 h in advance could confer a good protection against the infection with the S. tryphimurium LT2 strain.

Original languageEnglish
Pages (from-to)49-56
Number of pages8
JournalInternational Journal of Immunopharmacology
Volume12
Issue number1
DOIs
Publication statusPublished - 1990
Externally publishedYes

Fingerprint

Salmonella
Interferons
Lipopolysaccharides
Chediak-Higashi Syndrome
Salmonella enteritidis
Peritoneal Cavity
Phagocytes
Infection
Intraperitoneal Injections
Spleen
Bacteria
Mutation
Injections
Liver
Growth

ASJC Scopus subject areas

  • Immunology
  • Pharmacology

Cite this

Effect of murine recombinant interferon-γ in the protection of mice against salmonella. / Matsumura, Haruo; Onozuka, Kazuyasu; Terada, Yasuhiko; Nakano, Yasunobu; Nakano, Masayasu.

In: International Journal of Immunopharmacology, Vol. 12, No. 1, 1990, p. 49-56.

Research output: Contribution to journalArticle

Matsumura, Haruo ; Onozuka, Kazuyasu ; Terada, Yasuhiko ; Nakano, Yasunobu ; Nakano, Masayasu. / Effect of murine recombinant interferon-γ in the protection of mice against salmonella. In: International Journal of Immunopharmacology. 1990 ; Vol. 12, No. 1. pp. 49-56.
@article{c44b79cf62004d3a8a622e300b3a700f,
title = "Effect of murine recombinant interferon-γ in the protection of mice against salmonella",
abstract = "The ability of recombinant murine (rMu) interferon (IFN) -γ to activate anti-Salmonella-activity in normal mice and beige mutant (bg/bg) mice with Chediak-Higashi syndrome (CHS) was examined. Previous intraperitoneal (i.p.) injection of rMuIFN-γ (104 U per mouse) significantly hindered the bacterial growth in the peritoneal cavities, spleens and livers of the mice after the i.p. infection with Salmonella enteritidis No. 11 strain. It was also effective on the beige mice that have phagocytic cells with a genetically impaired bactericidal function, suggesting that IFN-γ activates the pathway irrelevant to the beige mutation. The effect was the maximum, when IFN-γ was given 6 h before the challenge. The effect seemed to be due to the augmentation of bactericidal capacity rather than the prevention of systemic spread of bacteria. Recombinant human IFN-αA/D (102-106 U per mouse), which produced effects identical to those of murine IFN-β, did not show such a bactericidal effect. Bactericidal activity enhancement was also seen in mice that had been injected with a small amount of rMuIFN-γ (102 U) and bacterial lipopolysaccharide (LPS) (10 ng) together at 6 h before the challenge, although the IFN-γ or LPS alone at these doses produced very little if any effect. Bactericidal effect enhancement was seen in mice that had been injected with IFN-γ at 6 h and LPS at 3 h before the challenge, while it could be hardly seen in mice injected with them in a reversed order. The simultaneous injections of rMuIFN-γ and LPS at 6 h in advance could confer a good protection against the infection with the S. tryphimurium LT2 strain.",
author = "Haruo Matsumura and Kazuyasu Onozuka and Yasuhiko Terada and Yasunobu Nakano and Masayasu Nakano",
year = "1990",
doi = "10.1016/0192-0561(90)90067-W",
language = "English",
volume = "12",
pages = "49--56",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Effect of murine recombinant interferon-γ in the protection of mice against salmonella

AU - Matsumura, Haruo

AU - Onozuka, Kazuyasu

AU - Terada, Yasuhiko

AU - Nakano, Yasunobu

AU - Nakano, Masayasu

PY - 1990

Y1 - 1990

N2 - The ability of recombinant murine (rMu) interferon (IFN) -γ to activate anti-Salmonella-activity in normal mice and beige mutant (bg/bg) mice with Chediak-Higashi syndrome (CHS) was examined. Previous intraperitoneal (i.p.) injection of rMuIFN-γ (104 U per mouse) significantly hindered the bacterial growth in the peritoneal cavities, spleens and livers of the mice after the i.p. infection with Salmonella enteritidis No. 11 strain. It was also effective on the beige mice that have phagocytic cells with a genetically impaired bactericidal function, suggesting that IFN-γ activates the pathway irrelevant to the beige mutation. The effect was the maximum, when IFN-γ was given 6 h before the challenge. The effect seemed to be due to the augmentation of bactericidal capacity rather than the prevention of systemic spread of bacteria. Recombinant human IFN-αA/D (102-106 U per mouse), which produced effects identical to those of murine IFN-β, did not show such a bactericidal effect. Bactericidal activity enhancement was also seen in mice that had been injected with a small amount of rMuIFN-γ (102 U) and bacterial lipopolysaccharide (LPS) (10 ng) together at 6 h before the challenge, although the IFN-γ or LPS alone at these doses produced very little if any effect. Bactericidal effect enhancement was seen in mice that had been injected with IFN-γ at 6 h and LPS at 3 h before the challenge, while it could be hardly seen in mice injected with them in a reversed order. The simultaneous injections of rMuIFN-γ and LPS at 6 h in advance could confer a good protection against the infection with the S. tryphimurium LT2 strain.

AB - The ability of recombinant murine (rMu) interferon (IFN) -γ to activate anti-Salmonella-activity in normal mice and beige mutant (bg/bg) mice with Chediak-Higashi syndrome (CHS) was examined. Previous intraperitoneal (i.p.) injection of rMuIFN-γ (104 U per mouse) significantly hindered the bacterial growth in the peritoneal cavities, spleens and livers of the mice after the i.p. infection with Salmonella enteritidis No. 11 strain. It was also effective on the beige mice that have phagocytic cells with a genetically impaired bactericidal function, suggesting that IFN-γ activates the pathway irrelevant to the beige mutation. The effect was the maximum, when IFN-γ was given 6 h before the challenge. The effect seemed to be due to the augmentation of bactericidal capacity rather than the prevention of systemic spread of bacteria. Recombinant human IFN-αA/D (102-106 U per mouse), which produced effects identical to those of murine IFN-β, did not show such a bactericidal effect. Bactericidal activity enhancement was also seen in mice that had been injected with a small amount of rMuIFN-γ (102 U) and bacterial lipopolysaccharide (LPS) (10 ng) together at 6 h before the challenge, although the IFN-γ or LPS alone at these doses produced very little if any effect. Bactericidal effect enhancement was seen in mice that had been injected with IFN-γ at 6 h and LPS at 3 h before the challenge, while it could be hardly seen in mice injected with them in a reversed order. The simultaneous injections of rMuIFN-γ and LPS at 6 h in advance could confer a good protection against the infection with the S. tryphimurium LT2 strain.

UR - http://www.scopus.com/inward/record.url?scp=0025020413&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025020413&partnerID=8YFLogxK

U2 - 10.1016/0192-0561(90)90067-W

DO - 10.1016/0192-0561(90)90067-W

M3 - Article

VL - 12

SP - 49

EP - 56

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 1

ER -